Summary & Overview
HCPCS J7297: Levonorgestrel-Releasing Intrauterine Contraceptive System, 52 mg
HCPCS Level II code J7297 designates the 52 mg levonorgestrel-releasing intrauterine contraceptive system (Liletta). It identifies the device component of a long-acting reversible contraceptive used in outpatient gynecologic and family planning settings. Nationally, accurate use of this HCPCS Level II code supports appropriate device billing, inventory tracking, and policy compliance for contraceptive services that have implications for preventive care access and women's health coverage.
Key payers in the scope of this publication include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the device, where and how the service is typically delivered, and the payer landscape covered. The publication summarizes common billing considerations, typical sites of service, and the payer mix relevant to national reimbursement patterns. It also outlines what readers can expect regarding benchmarks and recent policy updates where available, and directs readers to additional resources for coding, claim submission, and coverage verification.
Data not available in the input is clearly noted where applicable.
Billing Code Overview
HCPCS Level II code J7297 represents the levonorgestrel-releasing intrauterine contraceptive system (Liletta), 52 mg. This code is used to report the device component of a long-acting, reversible contraceptive system that releases levonorgestrel over time to provide intrauterine contraception.
Service Type: Contraceptive device implantation (IUD) — levonorgestrel-releasing intrauterine system
Typical Site of Service: Outpatient ambulatory clinic or office, including gynecology practices and family planning clinics where intrauterine devices are supplied and may be inserted. Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 28-year-old person presents to an ambulatory gynecology clinic requesting long-acting reversible contraception. They have completed counseling about options and select a levonorgestrel-releasing intrauterine system (Liletta, J7297, 52 mg). The patient has a negative pregnancy test and no active pelvic infection. The clinical workflow includes pre-procedure counseling and consent, pregnancy testing, review of cervical infection risk and recent STI screen as indicated, pelvic exam and bimanual exam, placement of the intrauterine device under speculum visualization with sterile technique, post-placement instructions, and scheduling of a follow-up visit (commonly 4–12 weeks) to check threads and address concerns. Typical site of service is an outpatient physician office or ambulatory surgery center. The service type is a contraceptive device insertion and supply of the medication-eluting intrauterine contraceptive system. Common patient scenarios include routine contraception initiation, replacement at end of labeled duration, or replacement for heavy menstrual bleeding management when appropriate.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (standard claim) | Use when no special circumstances apply to the service. |